Native Flow-Induced Dispersion Analysis – Mass Spectrometry Enables Automated, Multiplexed Ligand Screening from Conventional, Nonvolatile Buffers #AC pubs.acs.org/doi/10.1021/...
Native Flow-Induced Dispersion Analysis – Mass Spectrometry Enables Automated, Multiplexed Ligand Screening from Conventional, Nonvolatile Buffers #AC pubs.acs.org/doi/10.1021/...
PPM1M, a LRRK2-counteracting, phosphoRab12-preferring phosphatase with potential link to Parkinsons disease https://www.biorxiv.org/content/10.1101/2025.03.19.644182v1
More than 2 decades ago the PINK1 protein was found to be linked to Parkinson's disease, but its structure and how it was activated was not known. Until @science.org today. A triumph for cryo-EM and structural biology, introducing new targets for drug intervention.
www.science.org/doi/10.1126/...
There are 16 random mutations - aim was to stabilize the recombinant kinase domain - the variant can be expressed in E. coli (in contrast to WT BRAF).
Another step in the DOGE apocalypse: pubmed has gone missing (at the moment): pubmed.ncbi.nlm.nih.gov
LRRK2 type-II inhibitor design strategy.
Aberrant increases in kinase activity of LRKK2 are associated with #PD. In this study, CRN Team Reck-Peterson designed & tested the first LRRK2-selective type-II kinase inhibitors 🧪
🔗 Check out the full #preprint: www.biorxiv.org/content/10.1...
An update with latest data available for graph of life expectancy vs health care expenditures per capita for 20 countries and one outlier.
Excited to share that dosing has begun in the Denali Phase 2a "BEACON" study of the investigational therapeutic BIIB122 in Parkinson's disease patients that carry a variant in LRRK2!
investors.denalitherapeutics.com/news-release...
Engineering and sculpturing a smaller easy-to-use CRBN for new drug discoveries
‘Easy to handle’ Cereblon – a new tool for drug discovery and molecular glue screening 👍
www.sciencedirect.com/science/arti...
Congrats to the Đikić lab and Merck KGaA, in collaboration with Enamine Ltd, the Nowak Lab, the Langer Lab and iBET 😀
#CRBN #TPD #PROTAC
For my first post on Bluesky, here is our BioID map of RAB GTPases! It was a collective effort from many in the lab initiated by Benoît, Raphaëlle, and Dominique and followed up extensively by Véronique! I'll happily share the associated data if anyone is interested. www.biorxiv.org/content/10.1...
Consoling: Chatting with AI can weaken beliefs in conspiracy narratives.
Suspicion: AI may be capable of tricking us into any belief...
www.science.org/doi/10.1126/...
MAGE-A3 degraders from the @craigmcrews.bsky.social
lab. Nice example of how ligand discovery with DEL screening can mesh into degrader workflows.
We definitely don’t know all the ins and outs of degrading proteins as a therapeutic mode. But every year more stuff gets clearer:
I’m growing tired of seeing “Hook effect” in the literature instead of “hook effect” — ffs people, it’s named after the shape of the dose-response curve, not everyone’s favorite pirate 🤦♂️
I spent my childhood in the GDR. I confirm this country was terrible. I remember the cognitive dissonance in school, avoiding classmates whose parents were probably Stasi informants, and mistrusting any authorities.
I guess growing up in a dictatorship still has a profound impact on my personality.
Developing biologics that modulate LRRK2 features:
# Cellular kinase activity
# Filament formation
# Overcome preferred orientation in cryo-EM
@asapresearch.bsky.social
www.jbc.org/article/S002...
New preprint available on Mechanism of human PINK1 activation at the TOM complex in a reconstituted system. Great collaboration featuring ASAP Project Manager, Sebastian Mathea and other researchers. Check it out! 🧪
www.biorxiv.org/content/10.1...